Ironwood Pharmaceuticals IRWD Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $361.51M+13.8% | $296.15M-15.7% | $338.99M-10.4% | $308.52M-23.0% | $317.68M-23.2% | ||
| $89.64M-20.7% | $95.14M-14.6% | $98.66M-18.9% | $106.02M-15.1% | $113.04M-12.4% | ||
| $70.03M-46.5% | $82.26M-43.0% | $96.55M-35.4% | $110.76M-25.8% | $130.93M-20.6% | ||
| $161.33M-39.0% | $197.65M-23.5% | $215.8M-22.7% | $235.18M-18.0% | $264.68M-81.2% | ||
| $200.18M+278% | $98.5M+5.8% | $123.19M+99.9% | $73.34M-3.5% | $53M+105% | ||
| 55.4%+38.7pp | 33.3%+6.8pp | 36.3%+20.1pp | 23.8%+4.8pp | 16.7%+266pp | ||
| $33.82M-0.2% | $32.75M-0.9% | $33.77M+3.8% | $34.76M+5.4% | $33.87M+23.9% | ||
| $4.91M+17.7% | $4.08M-8.8% | $3.4M-30.5% | $3.62M-34.0% | $4.17M-67.6% | ||
| -$28.71M+1.1% | -$28.48M-2.0% | -$29.62M-7.1% | -$30.43M-10.7% | -$29.03M-101% | ||
| $171.47M+615% | $70.03M+7.4% | $93.57M+127% | $42.91M-23.0% | $23.97M+102% | ||
| $69.29M+23.1% | $46.01M-28.5% | $65.02M-12.9% | $50.8M-35.7% | $56.31M-22.3% | ||
| $102.18M+416% | $24.02M+2,629% | $28.55M+1,259% | -$7.89M-186% | -$32.34M+96.9% | ||
| 28.3%+38.4pp | 8.1%+7.9pp | 8.4%+9.1pp | -2.6%-4.9pp | -10.2%+244pp | ||
| $0.60+386% | $0.13+1,400% | $0.15+600% | -$0.06-250% | -$0.21+96.9% | ||
| $0.64+405% | $0.16+1,700% | $0.18+700% | -$0.05-200% | -$0.21+96.9% | ||
| 684.3M+6.9% | 678.6M+6.5% | 675.7M+6.8% | 658.1M-0.1% | 640.3M-2.3% | ||
| 649.2M+1.6% | 646.8M+1.8% | 644M+1.9% | 641.5M+2.1% | 638.8M+2.3% | ||
| $61.07M-2.6% | $42.55M-37.5% | $83.65M+43.5% | $63.56M-2.0% | $62.71M+1.7% | ||
| $1.85M-6.7% | $1.88M-6.5% | $1.91M-6.5% | $1.94M-4.9% | $1.98M+9.7% | ||
| —— | —— | —— | —— | —— | ||
| —— | $3.54M-57.9% | $4.76M-45.9% | $5.98M-34.9% | $7.19M-24.8% | ||
| -$8.03M-520% | $6.52M+132% | $767K— | -$9.93M— | $1.91M— | ||
| $66.07M— | -$35.15M— | —— | —— | —— | ||
| -$2.42M-8.8% | -$2.37M-9.0% | -$2.32M-9.0% | -$2.27M-9.0% | -$2.23M-9.1% | ||
| $3.7M+133% | $4.11M+140% | -$17.57M— | -$13.35M— | -$11.24M— | ||
| -$427K— | -$447K— | —— | —— | —— | ||
| -$6.77M— | -$367K— | -$1.55M— | —— | —— | ||
| —— | $30.33M-6.8% | $30.89M+11.1% | $31.45M+36.4% | $32.01M+74.8% | ||
| $4.91M+17.7% | $4.08M-8.8% | $3.4M-30.5% | $3.62M-34.0% | $4.17M-67.6% | ||
| —— | $216K+100% | -$14.79M— | -$41.95M— | -$91.41M— | ||
| —— | -$35K+75.4% | -$35K+99.2% | -$49K+99.8% | -$105K+100.0% | ||
| —— | —— | —— | —— | $78.52M-47.0% | ||
| $1.72M+8.4% | $1.69M+8.3% | $1.66M— | $1.62M— | $1.59M— | ||
| $198K-61.7% | $193K-69.8% | $276K— | $396K— | $517K— | ||
| —— | $35K-75.4% | $35K-90.1% | $49K-87.3% | $105K-68.0% | ||
| —— | $216K-98.0% | $297K-97.5% | $297K-97.5% | $958K-92.3% | ||
| $1.91M-90.8% | $20.51M+691% | $20.58M+555% | $18.4M+136% | $20.72M+10.5% | ||
| $361.51M+13.8% | $296.15M-15.7% | $338.99M-10.4% | $308.52M-23.0% | $317.68M-23.2% | ||
| $15.61M-41.7% | $17.25M-42.2% | $17.99M-47.1% | $22.71M-32.3% | $26.76M-19.6% | ||
| $200.18M+278% | $98.5M+5.8% | $123.19M+99.9% | $73.34M-3.5% | $53M+105% | ||
| $202.03M+272% | $100.38M+6.4% | $124.91M+98.8% | $74.89M-3.0% | $54.38M+105% | ||
| $202.03M+272% | $100.38M+6.4% | $124.91M+98.8% | $74.89M-3.0% | $54.38M+105% | ||
| 55.9%+38.8pp | 33.9%+7.1pp | 36.8%+20.2pp | 24.3%+5.0pp | 17.1%+266pp | ||
| $200.18M+278% | $98.5M+5.8% | $123.19M+99.9% | $73.34M-3.5% | $53M+105% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Ironwood Pharmaceuticals's revenue?
- Ironwood Pharmaceuticals (IRWD) generated $361.5M in revenue over the trailing twelve months, up 13.8% year over year.
- Is Ironwood Pharmaceuticals profitable?
- Ironwood Pharmaceuticals reported $102.2M in net income over the trailing twelve months, a 28.3% net margin.
- What are Ironwood Pharmaceuticals's profit margins?
- Gross margin is 99.2% and operating margin is 55.4%, with a 28.3% net margin.
- What is Ironwood Pharmaceuticals's earnings per share?
- Ironwood Pharmaceuticals's diluted EPS over the trailing twelve months is $0.60.
- Where does Ironwood Pharmaceuticals's income statement data come from?
- Every line is extracted from Ironwood Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
